{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:20:00Z","timestamp":1769120400758,"version":"3.49.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004742","name":"National Academy of Sciences of Ukraine","doi-asserted-by":"publisher","award":["0122U001977"],"award-info":[{"award-number":["0122U001977"]}],"id":[{"id":"10.13039\/501100004742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Endometrial cancer is the most prevalent gynecologic malignancy with a high risk of recurrence. Local recurrence occurs in 7\u201320% of patients with treated stage I cancer within 3 years after primary treatment. In this study, we found significantly elevated mRNA expression levels of the oncoprotein <jats:italic>KRAS<\/jats:italic>, along with two replicative stress markers, <jats:italic>ATR<\/jats:italic> and <jats:italic>CHEK1<\/jats:italic>, in samples of endometrial carcinomas of endometrium (ECE) from patients with relapse. In contrast, mRNA expression levels of the studied genes were low and uniform in samples from patients without relapse. Elevated levels of KRAS protein and the phosphorylated form of ATR\/CHEK1 were distinguishing features of recurrent ECE. A strong positive correlation was found between elevated mRNA and protein levels of the studied molecules. Elevated KRAS protein levels are characteristic of poorly differentiated (G3) endometrial carcinomas with deep myometrial invasion in patients without recurrence. In contrast, in patients with recurrence, higher protein levels of KRAS, pATR and pCHEK1 were observed in samples of G1-2 endometrial carcinomas, with statistically significant differences confirmed for pATR. High pCHEK1 protein levels are associated with deep tumor invasion in the myometrium among patients with recurrence. ROC analysis confirmed that evaluating the specificity and sensitivity of KRAS, pATR and pCHEK1 predicts recurrence development in patients with ECE. Our findings indicate that markers of replicative stress may play a significant role in ECE pathogenesis. Determining their levels in tumor samples after primary treatment could help define patients at high risk of recurrence and guide consequent courses of treatment.<\/jats:p>","DOI":"10.1371\/journal.pone.0302075","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T17:24:40Z","timestamp":1714152280000},"page":"e0302075","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence"],"prefix":"10.1371","volume":"19","author":[{"given":"Liubov","family":"Buchynska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3759-6138","authenticated-orcid":true,"given":"Inna","family":"Gordiienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadiia","family":"Glushchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliia","family":"Iurchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"issue":"4","key":"pone.0302075.ref001","doi-asserted-by":"crossref","first-page":"365","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-4.17052","article-title":"Features of recurrence of endometrioid type endometrial cancer of I stage","volume":"43","author":"OM Movchan","year":"2021","journal-title":"Experimental oncology"},{"issue":"1","key":"pone.0302075.ref002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"N Concin","year":"2021","journal-title":"International journal of gynecological cancer: official journal of the International Gynecological Cancer Society"},{"issue":"4","key":"pone.0302075.ref003","doi-asserted-by":"crossref","first-page":"300","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-4.15450","article-title":"Molecular phenotype of high-grade endometrioid carcinoma of the endometrium","volume":"42","author":"LG Buchynska","year":"2020","journal-title":"Experimental oncology"},{"issue":"13","key":"pone.0302075.ref004","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41388-022-02221-0","article-title":"Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression","volume":"41","author":"A Mota","year":"2022","journal-title":"Oncogene"},{"issue":"5","key":"pone.0302075.ref005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1158\/2159-8290.CD-17-1461","article-title":"Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place","volume":"8","author":"P Kotsantis","year":"2018","journal-title":"Cancer discovery"},{"issue":"1","key":"pone.0302075.ref006","article-title":"DNA replication stress: oncogenes in the spotlight","volume":"43","author":"LMF Primo","year":"2019","journal-title":"Genetics and molecular biology"},{"issue":"1","key":"pone.0302075.ref007","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"MK Zeman","year":"2014","journal-title":"Nature cell biology"},{"issue":"7","key":"pone.0302075.ref008","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: more than two types","volume":"15","author":"R Murali","year":"2014","journal-title":"The Lancet Oncology"},{"key":"pone.0302075.ref009","doi-asserted-by":"crossref","first-page":"215804","DOI":"10.1016\/j.canlet.2022.215804","article-title":"Mechanisms used by cancer cells to tolerate drug-induced replication stress","volume":"544","author":"HA Segeren","year":"2022","journal-title":"Cancer letters"},{"issue":"8","key":"pone.0302075.ref010","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/ijgc-2020-001277","article-title":"Exploiting replicative stress in gynecological cancers as a therapeutic strategy","volume":"30","author":"NY Ngoi","year":"2020","journal-title":"International journal of gynecological cancer: official journal of the International Gynecological Cancer Society"},{"issue":"23","key":"pone.0302075.ref011","doi-asserted-by":"crossref","first-page":"36996","DOI":"10.18632\/oncotarget.16940","article-title":"Potential biomarkers of DNA replication stress in cancer","volume":"8","author":"L Ren","year":"2017","journal-title":"Oncotarget"},{"key":"pone.0302075.ref012","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1017\/erm.2020.3","article-title":"DNA damage checkpoint kinases in cancer","volume":"22","author":"HL Smith","year":"2020","journal-title":"Expert reviews in molecular medicine"},{"key":"pone.0302075.ref013","first-page":"307","volume-title":"WHO classification of tumours of the female reproductive organs (IARC WHO Classification of Tumours)","author":"RJ Kurman","year":"2014","edition":"4"},{"issue":"1","key":"pone.0302075.ref014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"D. Hanahan","year":"2022","journal-title":"Cancer discovery"},{"key":"pone.0302075.ref015","doi-asserted-by":"crossref","first-page":"581217","DOI":"10.3389\/fonc.2020.581217","article-title":"Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors","volume":"10","author":"M Gachechiladze","year":"2020","journal-title":"Frontiers in oncology"},{"issue":"1","key":"pone.0302075.ref016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15407\/oncology.2023.01.039","article-title":"The value of the expression of K-RAS and DNA-status in the progression of endometrioid endometrial carcinoma in patients with early stages of tumor process","volume":"25","author":"NP Iurchenko","year":"2023","journal-title":"Oncologiya"},{"issue":"1","key":"pone.0302075.ref017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-020-00874-6","article-title":"Participation of the ATR\/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer","volume":"13","author":"P Gralewska","year":"2020","journal-title":"Journal of hematology & oncology"},{"issue":"21","key":"pone.0302075.ref018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218273","article-title":"Targeting DNA Damage Response in Prostate and Breast Cancer","volume":"21","author":"AM Wengner","year":"2020","journal-title":"International journal of molecular sciences"},{"issue":"7","key":"pone.0302075.ref019","first-page":"3909","article-title":"Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance","volume":"35","author":"B Lee","year":"2015","journal-title":"Anticancer research"},{"issue":"3","key":"pone.0302075.ref020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.molonc.2014.10.013","article-title":"Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer","volume":"9","author":"TM Abdel-Fatah","year":"2015","journal-title":"Molecular oncology"},{"issue":"23","key":"pone.0302075.ref021","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1158\/0008-5472.CAN-10-2286","article-title":"Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner","volume":"70","author":"O Gilad","year":"2010","journal-title":"Cancer research"},{"issue":"7924","key":"pone.0302075.ref022","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41586-022-05082-5","article-title":"Ordered and deterministic cancer genome evolution after p53 loss","volume":"608","author":"T Baslan","year":"2022","journal-title":"Nature"},{"key":"pone.0302075.ref023","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920982853","article-title":"ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer","volume":"12","author":"W Feng","year":"2020","journal-title":"Therapeutic advances in medical oncology"},{"issue":"3","key":"pone.0302075.ref024","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ygyno.2014.12.035","article-title":"Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells","volume":"136","author":"PN Teng","year":"2015","journal-title":"Gynecologic oncology"},{"issue":"4","key":"pone.0302075.ref025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14728214.2019.1696773","article-title":"Emerging serine-threonine kinase inhibitors for treating ovarian cancer","volume":"24","author":"A Maoz","year":"2019","journal-title":"Expert opinion on emerging drugs"},{"issue":"8","key":"pone.0302075.ref026","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3390\/jcm12083014","article-title":"Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?","volume":"12","author":"Y Li","year":"2023","journal-title":"J Clin Med"},{"key":"pone.0302075.ref027","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ygyno.2015.06.038","article-title":"Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology\/Gynecologic Oncology Group study","volume":"138","author":"I Zighelboim","year":"2015","journal-title":"Gynecol. Oncol"},{"issue":"19","key":"pone.0302075.ref028","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2008.19.9802","article-title":"ATR Mutation in Endometrioid Endometrial Cancer Is Associated With Poor Clinical Outcomes","volume":"27","author":"I Zighelboim","year":"2009","journal-title":"J Clin Oncol"},{"key":"pone.0302075.ref029","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/bjc.2012.477","article-title":"KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer","volume":"107","author":"E. Birkeland","year":"2012","journal-title":"Br J Cancer"},{"key":"pone.0302075.ref030","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00432-021-03566-x","article-title":"In search for biomarkers and potential drug targets for uterine serous endometrial cancer","volume":"147","author":"G. Dinoi","year":"2021","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0302075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T17:25:00Z","timestamp":1714152300000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0302075"}},"subtitle":[],"editor":[{"given":"Canhui","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0302075","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}